Showing 1 posts of 1 posts found.
Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Bramacare opens supported-living facility for eating disorder recovery
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland